Table of Contents

Contributors

PART I: PRIMARY TUMOUR EVALUATION AND STAGING

1. Tumours of the oral cavity and pharynx

Kunwar S. S. Bhatia, Ann D. King, and Robert Hermans

2. Paranasal sinus and nasal cavity neoplasms

Sofia Otero and Tim Beale

3. Laryngeal tumours

Philip Touska, Steve Connor, and Robert Hermans

4. Thyroid cancer

Gitta Madani and Polly S. Richards

5. Mediastinal tumours

Jonathan Goldin

6. Lung cancer

Stephen M. Ellis and Zelena Aziz

7. Pleural tumours

Bhavin Rawal and Sujal R. Desai

8. Breast cancer

Sarah J. Vinnicombe and Alexandra Athanasiou

9. Oesophageal cancer

Nyree Griffin, Jason Dunn, and Lee Alexander Grant

10. Gastric cancer

Jacob S. Ecanow and Richard M. Gore

11. Primary tumours of the liver and biliary tract

Hero K. Hussain and Mohammad Abu Shattal

12. Pancreatic malignancy

Giovanni Morana, Alex Faccinetto, and Michele Fusaro

13. Renal cancer

Conrad von Stempel, Lee Alexander Grant, Miles Walkden, and Navin Ramachandran

14. Primary adrenal malignancy

Ayshea Hameeduddin, Anju Sahdev, and Rodney H. Reznek

15. Primary retroperitoneal tumours

Isaac R. Francis, Richard H. Cohan, and William R. Burns

16. Bladder cancer

Anju Sahdev

17. Prostate cancer

Jurgen J. Fütterer, Fillip Kossov, and Henkjan Huisman

18. Testicular cancer

Edward Nganga and Aslam Sohaib

19. Ovarian cancer

Stephanie Nougaret, Helen Addley, Evis Sala, and Anju Sahdev

20. Cervical and uterine tumours

Rosemarie Forstner and Andrea Rockall

21. Colorectal cancer

Svetlana Balyasnikova and Gina Brown

22. Primary bone tumours

Jennifer N. Murphy, Steven L. J. James, Murali Sundaram, and A. Mark Davies

23. Soft tissue sarcomas

Christina Messiou, Dirk Strauss, and Eleanor Moskovic

24. Neuroendocrine tumours

Sairah R. Khan, Kathryn L. Wallitt, Adil Al-Nahhas, and Tara D. Barwick

PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY

25. Lymphoma

Sarah J. Vinnicombe and Rodney J. Hicks

26. Multiple myeloma

Conor D. Collins

PART III: METASTASES

27. Brain metastases

Anant Subramanian Krishnan and Jane Evanson

28. Lymph node metastases

Dow-Mu Koh and Gigin Lin

29. Lung and pleural metastases

Matthew Gilman and Amita Sharma

30. Bone metastases

Rupert Berkeley, Muaaze Ahmad, and Rikin Hargunani

31. Liver and spleen metastases

Wolfgang Schima, Helmut Kopf, and Claus Kölblinger

32. Adrenal metastases

Khawaja Shahabuddin, Rodney H. Reznek, and Anju Sahdev

33. Peritoneal metastases

Louisa Firmin and Zahir Amin

PART IV: DISEASE RESPONSE AND TREATMENT

34. Assessment of response to treatment

Lawrence H. Schwartz, Binsheng Zhao, and Marius E. Mayerhoefer

35. Tumour-specific disease response criteria

Katja De Paepe and Nina Tunariu

36. Immunotherapy response

Bernhard Gebauer

PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS

37. Oncological effects on the central nervous system

Jane Evanson

38. Effects of treatment on the thorax

Dhakshina Moorthy Ganeshan, Herman I. Libshitz, and Revathy B. Iyer

39. Effects of treatment on the abdomen and pelvis

Rohit Kochhar and Philip Borg

40. Effects of treatment on bone and bone marrow

Lia A. Moulopoulos and Vassilis Koutoulidis

PART VI: FUNCTIONAL AND MOLECULAR IMAGING

41. PET-CT: Principles and clinical applications

Mario Jreige, Marie Nicod-Lalonde, John O. Prior, and Niklaus Schaefer

42. Functional imaging and emerging techniques in MRI

Roberto García-Figueiras, Anwar Padhani, and Sandra Baleato-González

43. Functional imaging and emerging techniques in CT

Vicky Goh, Christian Kelly-Morland, and Davide Prezzi

44. Non-FDG radionuclide imaging and targeted therapies

Luigi Aloj and Ferdia A. Gallagher

Index